Add-on therapy with the DPP-4 inhibitor sitagliptin improves glycemic control in insulin-treated Japanese patients with type 2 diabetes mellitus. 2013/02/01 池田病院の活動 Katsuno T, Ikeda H, Ida K, Miyagawa J, Namba M. 「 Endocr.J 2013;60(6):733-42 Epub 2013 Feb2. 」